Recent Advances in Novasome Formulation Technology
DOI:
https://doi.org/10.37285/ijpsn.2014.7.2.1Abstract
Pharmaceutical technology has developed various newer modes of novel drug delivery aspects. Modifications in the previously existing drug delivery methods have led to various newly innovated technologies serving as a safe and effective means of improvement over the existing ones. Novasome technology is one of the new innovations of liposomes which have solved many of the problems related to liposomal drug delivery system. It offers a seven bilayer membrane which has the ability to incorporate both water soluble and insoluble drugs. It has an excellent entrapment efficiency which provides better medication. Formulation of novasomes is achieved in a high shear device. Due to its numerous advantages, novasomes have been used extensively in various fields like cosmetics, chemical, personal care, foods, pharmaceuticals and agrochemicals.
Downloads
Metrics
Keywords:
Novasome, Non phospholipids, Paucilamellar, Innovation
Downloads
Published
How to Cite
Issue
Section
References
Chambers MA, Wright DC, Brisker J, Williams AG, Hatch, Widen GD, Hall G, Marsh PD and Hewinson RG (2004). A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome™) protects guinea pigs from lethal tuberculosis. Vaccine 22(6): 1063-71.
Craig Wright D(1997). Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal topical delivery of peptide drugs into activity. U.S patent 5561062.
Gupta RK, Varanelli CL, Griffin P, Wallach DFH and Siber GR (1996). Adjuvant properties of non-phospholipid liposomes (NovasomesR) in experimental animals for human vaccine antigens.Vaccine 14(3): 219- 25.
Holick MF, Chimeh FN and Ray S (2003). Topical PTH (1-34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial. British J Dermatol 149(2): 370-376
Lasic DD (1997). Liposomes and Niosomes. In: Surfactants in Cosmetics, Eds., M.M. Rieger and L.D. Rhein, Marcel Dekker: New York, pp: 263-283.
Mills R, Mathur Rand Lawrence N (2007). Mahonia aquifolim extract, Extraction process and pharmaceutical composition containing the same. U.S. Patent 20,070,148,226.
Pinsky MA (2010). Materials and Methods for Delivering Antioxidants into the Skin.U.S. Patent 20,100,098,752.
Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, Smith G, Wright DC and Bright RA (2007). Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.Vaccine 25(21): 4283-90.
Vandegriff KD, Wallach DFH and Winslow RM (1994). Encapsulation of Hemoglobin in Non-Phospholipid Vesicles. Artificial Cells, Blood Substitutes and Biotechnology 22(3): 849-854.
Varanelli C, Kumar S and Wallach DFH (1996). Method of inhibiting viral reproduction using non-phospholipid, paucilamellar liposomes. U.S. Patent 5,561,062.
Wallach DFH, Mathur R, Redziniak GJM and Tranchant JF (1992). Some properties of N-acyl sarcosinate lipid vesicles. Journal of the Society of Cosmetic Chemists 43(2): 113-8.
Weiner N, Wallach DFH, Egbaria K and Chandrasekharan R (1998). Stimulation of hair follicles. U.S.Patent 5,834,014.
Williams A.C (2003). Transdermal and topical drug delivery from theory to clinical practice. Pharmaceutical Press: United Kingdom.
Wright DC (1997). Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity. U.S. Patent 5,700,679
Wright DC (1998). Oral vaccine against gram negative bacterial infection.U.S. Patent 5,730,989.
